arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Hims & Hers Health, Inc.

HIMS
$23.55 ▼ -3.11 (-11.67%) at close
Industrials ·Services-Offices & Clinics of Doctors of Medicine ·USServices-Offices & Clinics of Doctors of Medicine
31 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
74
Health
Good
Bullish
auto_awesome

Analytical Summary

Hims & Hers Health, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $5.5B
Dividend Yield —
Revenue Growth 38.2% ↗
Op. Margin -12.9% →
ROIC -27.9% ↘
FCF / Share $-0.16 ↘
Trailing P/E —
Price / Book 16.8x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

31-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$753.21M
↑ +38.2% —
Net Income Profit after all expenses
$-92.11M
— 0.0% —
Operating Margin Operating profit as % of sales
-12.9%
— -0.2% 41th
FCF / Share Free cash flow per share
$-0.16
↓ -139.6% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
54
Returns
89
Cash Quality ↑
89

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 8 years · 31 quarters